Page last updated: 2024-09-02

florfenicol and vanoxerine

florfenicol has been researched along with vanoxerine in 1 studies

Compound Research Comparison

Studies
(florfenicol)
Trials
(florfenicol)
Recent Studies (post-2010)
(florfenicol)
Studies
(vanoxerine)
Trials
(vanoxerine)
Recent Studies (post-2010) (vanoxerine)
62870420556593

Protein Interaction Comparison

ProteinTaxonomyflorfenicol (IC50)vanoxerine (IC50)
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.5098
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.0103
Sodium-dependent serotonin transporterHomo sapiens (human)1.5513
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.0969
Small conductance calcium-activated potassium channel protein 2Rattus norvegicus (Norway rat)0.073
Small conductance calcium-activated potassium channel protein 3Rattus norvegicus (Norway rat)0.073
Small conductance calcium-activated potassium channel protein 1Rattus norvegicus (Norway rat)0.073
Sodium-dependent dopamine transporter Homo sapiens (human)0.0424
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.022
TransporterRattus norvegicus (Norway rat)0.114

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alderwick, LJ; Bacon, J; Besra, GS; Jeeves, RE; Kanvatirth, P1

Other Studies

1 other study(ies) available for florfenicol and vanoxerine

ArticleYear
Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria.
    PloS one, 2019, Volume: 14, Issue:3

    Topics: Agar; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Drug Design; Drug Repositioning; Green Fluorescent Proteins; Hep G2 Cells; Humans; Mutation; Mycobacterium bovis; Mycobacterium smegmatis; Mycobacterium tuberculosis; Pentamidine; Piperazines; Polymorphism, Single Nucleotide; Small Molecule Libraries; Thiamphenicol; Tuberculosis, Multidrug-Resistant; United States; United States Food and Drug Administration

2019